These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 19416155

  • 1. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
    Liu C, Kuei C, Sutton S, Shelton J, Zhu J, Nepomuceno D, Hossain MA, Wade JD, Bathgate RA, Bonaventure P, Lovenberg T.
    Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
    [Abstract] [Full Text] [Related]

  • 2. Relaxin-3, INSL5, and their receptors.
    Liu C, Lovenberg TW.
    Results Probl Cell Differ; 2008 Apr; 46():213-37. PubMed ID: 18236022
    [Abstract] [Full Text] [Related]

  • 3. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
    Kuei C, Sutton S, Bonaventure P, Pudiak C, Shelton J, Zhu J, Nepomuceno D, Wu J, Chen J, Kamme F, Seierstad M, Hack MD, Bathgate RA, Hossain MA, Wade JD, Atack J, Lovenberg TW, Liu C.
    J Biol Chem; 2007 Aug 31; 282(35):25425-35. PubMed ID: 17606621
    [Abstract] [Full Text] [Related]

  • 4. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
    Zhu J, Kuei C, Sutton S, Kamme F, Yu J, Bonaventure P, Atack J, Lovenberg TW, Liu C.
    Eur J Pharmacol; 2008 Aug 20; 590(1-3):43-52. PubMed ID: 18582868
    [Abstract] [Full Text] [Related]

  • 5. Structure and activity in the relaxin family of peptides.
    Tregear GW, Bathgate RA, Hossain MA, Lin F, Zhang S, Shabanpoor F, Scott DJ, Ma S, Gundlach AL, Samuel CS, Wade JD.
    Ann N Y Acad Sci; 2009 Apr 20; 1160():5-10. PubMed ID: 19416150
    [Abstract] [Full Text] [Related]

  • 6. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
    Hossain MA, Bathgate RA, Rosengren KJ, Shabanpoor F, Zhang S, Lin F, Tregear GW, Wade JD.
    Chem Biol Drug Des; 2009 Jan 20; 73(1):46-52. PubMed ID: 19152634
    [Abstract] [Full Text] [Related]

  • 7. Structural properties of relaxin chimeras.
    Haugaard-Jönsson LM, Hossain MA, Daly NL, Bathgate RA, Wade JD, Craik DJ, Rosengren KJ.
    Ann N Y Acad Sci; 2009 Apr 20; 1160():27-30. PubMed ID: 19416154
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3.
    Haugaard-Kedström LM, Shabanpoor F, Hossain MA, Clark RJ, Ryan PJ, Craik DJ, Gundlach AL, Wade JD, Bathgate RA, Rosengren KJ.
    J Am Chem Soc; 2011 Apr 06; 133(13):4965-74. PubMed ID: 21384867
    [Abstract] [Full Text] [Related]

  • 9. Development of a selective agonist for relaxin family peptide receptor 3.
    Wei D, Hu MJ, Shao XX, Wang JH, Nie WH, Liu YL, Xu ZG, Guo ZY.
    Sci Rep; 2017 Jun 12; 7(1):3230. PubMed ID: 28607363
    [Abstract] [Full Text] [Related]

  • 10. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
    Shabanpoor F, Akhter Hossain M, Ryan PJ, Belgi A, Layfield S, Kocan M, Zhang S, Samuel CS, Gundlach AL, Bathgate RA, Separovic F, Wade JD.
    J Med Chem; 2012 Feb 23; 55(4):1671-81. PubMed ID: 22257012
    [Abstract] [Full Text] [Related]

  • 11. Recent progress in relaxin-3-related research.
    Liu C, Bonaventure P, Sutton SW, Chen J, Kuei C, Nepomuceno D, Lovenberg TW.
    Ann N Y Acad Sci; 2005 May 23; 1041():47-60. PubMed ID: 15956687
    [Abstract] [Full Text] [Related]

  • 12. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
    Zhang WJ, Jiang Q, Wang XY, Song G, Shao XX, Guo ZY.
    J Pept Sci; 2013 Jun 23; 19(6):350-4. PubMed ID: 23526726
    [Abstract] [Full Text] [Related]

  • 13. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
    Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ.
    Pharmacol Rev; 2006 Mar 23; 58(1):7-31. PubMed ID: 16507880
    [Abstract] [Full Text] [Related]

  • 14. Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system.
    Sutton SW, Shelton J, Smith C, Williams J, Yun S, Motley T, Kuei C, Bonaventure P, Gundlach A, Liu C, Lovenberg T.
    Ann N Y Acad Sci; 2009 Apr 23; 1160():242-9. PubMed ID: 19416196
    [Abstract] [Full Text] [Related]

  • 15. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
    Kristensson L, Mayer G, Ploj K, Wetterlund M, Arlbrandt S, Björquist A, Wissing BM, Castaldo M, Larsson N.
    Eur J Pharmacol; 2015 Jan 15; 747():123-31. PubMed ID: 25496752
    [Abstract] [Full Text] [Related]

  • 16. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
    van der Westhuizen ET, Werry TD, Sexton PM, Summers RJ.
    Mol Pharmacol; 2007 Jun 15; 71(6):1618-29. PubMed ID: 17351017
    [Abstract] [Full Text] [Related]

  • 17. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
    Sutton SW, Bonaventure P, Kuei C, Nepomuceno D, Wu J, Zhu J, Lovenberg TW, Liu C.
    Neuroendocrinology; 2005 Jun 15; 82(3-4):139-50. PubMed ID: 16679775
    [Abstract] [Full Text] [Related]

  • 18. Membrane receptors: structure and function of the relaxin family peptide receptors.
    Kong RC, Shilling PJ, Lobb DK, Gooley PR, Bathgate RA.
    Mol Cell Endocrinol; 2010 May 14; 320(1-2):1-15. PubMed ID: 20138959
    [Abstract] [Full Text] [Related]

  • 19. Receptors for relaxin family peptides.
    Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ.
    Ann N Y Acad Sci; 2005 May 14; 1041():61-76. PubMed ID: 15956688
    [Abstract] [Full Text] [Related]

  • 20. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids.
    Wang JH, Hu MJ, Zhang L, Shao XX, Lv CH, Liu YL, Xu ZG, Guo ZY.
    Biochimie; 2018 Nov 14; 154():77-85. PubMed ID: 30102931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.